Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process...
Reexamination Certificate
2005-06-07
2005-06-07
Minnifield, Nita (Department: 1645)
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
C435S069700, C435S252300, C435S252800, C424S093200, C424S184100
Reexamination Certificate
active
06902906
ABSTRACT:
The invention provides a bacterium attenuated by a non-reverting mutation in each of the aroC gene, the ompF gene and the ompC gene. The bacterium is useful as a vaccine. The bacterium may, for example, be an attenuated strain ofE. coliuseful in vaccination against diarrhoea.
REFERENCES:
patent: 5683700 (1997-11-01), Charles et al.
patent: 0 322 237 (1989-06-01), None
patent: 0 400 958 (1990-12-01), None
patent: 0 441 071 (1991-08-01), None
patent: 0 524 205 (1993-01-01), None
patent: 91/15572 (1991-10-01), None
patent: 92/15689 (1992-09-01), None
patent: WO 92/15689 (1992-09-01), None
Nogami et al, Journal of Bacteriology, Nov. 1985, p. 797-801.
Dougan et al, The Journal of Infectious Diseases, vol. 158, No. 6, Dec. 1988.
Chatfield et al, Infection and Immunity, Jan. 1991, p. 449-452.
Chatfield et al, Infection and Immunity, Jan. 1991, p. 449-452.
Dougan et al, The Journal of Infectious Diseases, vol. 158, No. 6, Dec. 1988.
Bacon et al, “The Effects of Biochemical Mutation on the Virulence ofBacterium typhosum:The Virulence of Mutants”, Br. J. Exp. Pathol. 31:714-724 (1950).
Chatfield et al, “Use of The nirB Promoter to Direct the Stable Expression of Heterologous Antigens in Salmonella Oral Vaccine Strains: Development of a Single-Dose Oral Tetanus Vaccine”, Bio/Technology 10:888-892 (1992).
Curtiss III et al,Salmonella typhimuriumDeletion Mutants Lacking Adenylate Cyclase and Cyclic AMP Receptor Protein Are Avirulent and Immunogenic, Infection and Immunity 55(12):3035-3043 (1987).
Dougan et al, “Construction and Characterization of Vaccine Strains of Salmonella Harboring Mutations in Two Difference aro Genes”, The Journal of Infectious Diseases 158(6):1329-1335 (1988).
Fairweather et al, “Oral Vaccination of Mice against Tetanus by Use of a Live Attenuated Salmonella Carrier”, Infection and Immunity 58(5):1323-1326 (1990).
Gomez-Duarte et al, “Expression of fragment C of tetanus toxin fused to a carboxyl-terminal fragment of diptheria toxin inSalmonella typhiCVD 908 vaccine strain”, Vaccine 13(16):1596-1602 (1995).
Hohmann et al, “Evaluation of a phoPlphoQ-deleted, aroA-deleted live oral Salmonella typhi vaccine strain in human volunteers”, Vaccine 14(1):19-24 (1996).
Hone et al, “Construction of Defined galE Mutants of Salmonella for Use as Vaccines”, The Journal of Infectious Diseases 156(1):167-174 (1987).
Jones et al, “Oral vaccination of calves against experimental salmonellosis using a double aro mutant ofSalmonella typhimurium”, Vaccine 9:29-34 (1991).
Miller et al, “A two-component regulatory system (phoP phoQ) controlsSalmonella typhimuriumvirulence”, Proc. Natl. Acad. Sci. USA 86:5054-5058 (1989).
Pickard et al, “Characterization of Defined ompR Mutants ofSalmonella typhi.ompR Is Involved in the Regulation of Vi Polysaccharide Expression”, Infection and Immunity 62(9):3984-3993 (1994).
Strugnell et al, “Characterization of aSalmonella typhimuriumaro Vaccine Strain Expressing the P.69 Antigen ofBordetella pertussis”, Infection and Immunity 60(10):3994-4002 (1992).
Everest et al, “Expression of LacZ from the htrA, nirB and groE promoters in a Salmonella vaccine strain: Influence of growth in mammalian cells”, FEMS Microbiology Letters 126:97-102 (1995).
Chatfield et al, “Role of ompR-Dependent Genes inSalmonella typhimuriumVirulence: Mutants Deficient in Both OmpC and OmpF Are Attenuated In Vivo”, Infection and Immunity 59(1):449-452 (1991).
Donnenberg and Kaper, “Construction of an eae Deletion Mutant of EnteropathogenicEscherichia coliby Using a Positive-Selection Suicide Vector”, Infection and Immunity 59(12):4310-4317 (1991).
Cersini A. et al.: “Intracellular Multiplication and Virulence of Shigella flexbneri Auxotrophic Mutants.” Infection and Immunity, (1998) 66/2, pp. 549-557.
Cobos A. et al.: “Transposon-generated Tn10 Insertion Mutations at the aro Genes ofEscherichia coliK-12” Curr Microbiol, (1990) 20 (1), pp 13-18.
Dorman C.J. et al.: “Characterization of Porin and ompR Mutants of a Virulent Strain ofSalmonella typhimurium:ompR Mutants Are Attenuated In Vivo” Infect Immun, (1989) 57 (7), pp. 2136-2140.
Levine, Myron M. (1) et al.: “Attenuated monella as live oral vaccines against typhoid fever and as live vectors” Journal of Biotechnology, (1996) vol. 44, No. 1-3, pp. 193-196.
Lowe, David C. et al.: “Characterization of Candidate Live OralSalmonella typhiVaccine Strains Harboring Defined Mutations in aroA, aroC, and htrA” 67, No. 2, pp. 700-707.
S. N. Chatfield et al.: “Evaluation ofSalmonella typhimuriumstrains harbouring defined mutations in htrA and aroA in the murine salmonellosis model” Microbial Pathogenesis, (1992) vol. 12, pp. 145-151.
S. N. Chatfield et al.: “Role of ompR-Dependent Genes inSalmonella typhimuriumVirulence: Mutants Deficient in Both OmpC and OmpF Are Attenuated In Vivo” Infection and Immunity, (Jan. 1991)vol. 59, No. 1, pp. 449-452.
T. Nogami et al.: “Construction of a Series of ompF-ompC Chimeric Genes by In Vivo Homologous Recombination inEscherichia coliand Characterization of the Translational Products” Journal of Bacteriology, (Nov. 1985) vol. 164, No. 2, pp. 797-801.
J. M. Slauch et al.: “cis-Acting ompF Mutations That Result in OmpR-Dependent Constitutive Expression” Journal of Bacteriology, (Jul. 1991) vol. 173, No. 13, pp. 4039-4048.
I.G. Charles et al.: “Isolation, characterization and nucleotide sequences of the aroC genes encoding chorismate synthase fromSalmonella typhiandEscherichia coli” Journal of General Microbiology, (Feb. 1990) vol. 136, No. 2, pp. 353-358.
Acambis Research Limited
Ford Vanessa L.
Minnifield Nita
Nixon & Vanderhye P.C.
LandOfFree
Bacteria attenuated by a non-reverting mutation in each of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bacteria attenuated by a non-reverting mutation in each of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bacteria attenuated by a non-reverting mutation in each of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3522546